8-K - BICYCLE THERAPEUTICS PLC (0001761612) (Filer)
Published . Updated .
8-K - BICYCLE THERAPEUTICS filed an 8-K with the SEC on Oct 29 (a notice of a material company event).
Directly affected
- BCYC Bicycle Therapeutics
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Bicycle Therapeutics belongs to, so it often moves with news about it.
- NVS Novartis AG+1.3% 17d
Novartis AG is a peer of Bicycle Therapeutics in pharmaceutical preparations; rivals often move on the same news.
- AZN AstraZeneca+11.1% 30d
AstraZeneca is a peer of Bicycle Therapeutics in pharmaceutical preparations; rivals often move on the same news.
- NVO Novo Nordisk A/S-7.3% 30d
Novo Nordisk A/S is a peer of Bicycle Therapeutics in pharmaceutical preparations; rivals often move on the same news.
- GSK Gsk-6.3% 10d
Gsk is a peer of Bicycle Therapeutics in pharmaceutical preparations; rivals often move on the same news.
- SNY Sanofi
Sanofi is a peer of Bicycle Therapeutics in pharmaceutical preparations; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| BCYC | -6.32% | -5.81% | base | -1.42% | -5.29% | after close | after close |
| XLVNo price data for this ticker | — | — | — | — | — | — | — |
| NVSNo price data for this ticker | — | — | — | — | — | — | — |
| AZNNo price data for this ticker | — | — | — | — | — | — | — |
| NVONo price data for this ticker | — | — | — | — | — | — | — |
| GSKNo price data for this ticker | — | — | — | — | — | — | — |
| SNYNo price data for this ticker | — | — | — | — | — | — | — |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Filed: 2026-10-29 AccNo: 0001104659-26-119858 Size: 310 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
The price since 29 Oct 2026: Bicycle Therapeutics (BCYC) versus the S&P 500
| Company | When | Move | Status |
|---|---|---|---|
| Bicycle Therapeutics (BCYC) | that day | -1.42% | final price |
| Bicycle Therapeutics (BCYC) | the next day | -5.29% | final price |
| Bicycle Therapeutics (BCYC) | three days earlier | -5.81% | final price |
| Bicycle Therapeutics (BCYC) | five days earlier | -6.32% | final price |
Congressional trades in the stocks in this story
- Rep. Kevin Hern sold Novartis Ag (NVS), worth $15,001 - $50,000 on 27 Aug 2026. That is 63 days before publication. Filed 25 Sep 2026. View the filing.
- Rep. Kevin Hern sold Novo Nordisk A S (NVO), worth $1,001 - $15,000 on 10 Sep 2026. That is 49 days before publication. Filed 25 Sep 2026. View the filing.
- Rep. Kevin Hern sold Novo Nordisk A S (NVO), worth $1,001 - $15,000 on 31 Aug 2026. That is 59 days before publication. Filed 25 Sep 2026. View the filing.
- Rep. Scott Scott Franklin bought Novo Nordisk A S (NVO), worth $1,001 - $15,000 on 26 Aug 2026. That is 64 days before publication. Filed 17 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Bicycle Therapeutics (BCYC)
Companies carried with this story
- BCYC Bicycle Therapeutics
For “8-K - BICYCLE THERAPEUTICS PLC (0001761612) (Filer),” Bicycle Therapeutics (BCYC) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> BCYC
How “8-K - BICYCLE THERAPEUTICS PLC (0001761612) (Filer)” reaches Bicycle Therapeutics (BCYC)
On 29 Oct 2026, “8-K - BICYCLE THERAPEUTICS PLC (0001761612) (Filer)” is the story that connects Bicycle Therapeutics (BCYC) to this story.
Bicycle Therapeutics (BCYC) is on the page because SEC 8-K filing -> direct issuer disclosure -> BCYC
Dates in the story, and the Bicycle Therapeutics (BCYC) price range
BCYC traded between 3.60 and 4.13 across 2 sessions. The latest close on file is 3.67.
How strong the case is around Bicycle Therapeutics (BCYC)
14 out of 100
“8-K - BICYCLE THERAPEUTICS PLC (0001761612) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.